HighTower Advisors, LLC - ZIOPHARM ONCOLOGY INC ownership

ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 130 filers reported holding ZIOPHARM ONCOLOGY INC in Q1 2019. The put-call ratio across all filers is 0.84 and the average weighting 0.1%.

Quarter-by-quarter ownership
HighTower Advisors, LLC ownership history of ZIOPHARM ONCOLOGY INC
ValueSharesWeighting
Q3 2023$7,000
-75.0%
55,0750.0%0.00%
Q2 2023$28,000
+12.0%
55,075
+37.4%
0.00%
Q1 2023$25,0000.0%40,0740.0%0.00%
Q4 2022$25,000
-63.8%
40,074
-0.5%
0.00%
Q3 2022$69,000
+25.5%
40,275
-19.9%
0.00%
Q2 2022$55,000
+103.7%
50,275
+17.5%
0.00%
Q1 2022$27,000
-41.3%
42,7750.0%0.00%
Q4 2021$46,000
-51.6%
42,775
-17.5%
0.00%
Q3 2021$95,000
-30.1%
51,875
+0.7%
0.00%
Q2 2021$136,000
-36.2%
51,491
-12.7%
0.00%
-100.0%
Q1 2021$213,000
+70.4%
58,991
+18.2%
0.00%0.0%
Q3 2020$125,000
-61.9%
49,891
-49.9%
0.00%
-50.0%
Q2 2020$328,000
+1.9%
99,666
-24.1%
0.00%0.0%
Q1 2020$322,000
-49.4%
131,274
-2.8%
0.00%
-50.0%
Q4 2019$636,000
-1.9%
135,074
-10.8%
0.00%0.0%
Q3 2019$648,000
-21.6%
151,501
+6.6%
0.00%
-20.0%
Q2 2019$827,000
+39.0%
142,176
-8.3%
0.01%
+25.0%
Q1 2019$595,000
+200.5%
154,976
+45.4%
0.00%
+100.0%
Q4 2018$198,000
-41.2%
106,580
+0.9%
0.00%0.0%
Q3 2018$337,000
+9.8%
105,676
+2.7%
0.00%0.0%
Q2 2018$307,000
-28.1%
102,876
-5.2%
0.00%
-50.0%
Q1 2018$427,000
+31.0%
108,576
+37.5%
0.00%
+33.3%
Q4 2017$326,000
+15.6%
78,976
+71.2%
0.00%
+50.0%
Q3 2017$282,000
-6.0%
46,122
-4.5%
0.00%
-33.3%
Q2 2017$300,000
-22.7%
48,310
-21.1%
0.00%
-25.0%
Q1 2017$388,000
+17.9%
61,194
-0.8%
0.00%0.0%
Q4 2016$329,000
-8.9%
61,694
-3.4%
0.00%0.0%
Q3 2016$361,000
+86.1%
63,864
+80.1%
0.00%
+100.0%
Q2 2016$194,000
-31.0%
35,454
-6.6%
0.00%
+100.0%
Q1 2016$281,000
-3.1%
37,954
+7.4%
0.00%
-66.7%
Q4 2015$290,000
-37.6%
35,349
-32.0%
0.00%
-50.0%
Q3 2015$465,000
+9.2%
51,981
+46.6%
0.01%
-14.3%
Q2 2015$426,000
+20.0%
35,465
+7.7%
0.01%
+40.0%
Q1 2015$355,000
+277.7%
32,935
+78.0%
0.01%
+400.0%
Q4 2014$94,000
+91.8%
18,5000.0%0.00%0.0%
Q3 2014$49,000
-23.4%
18,500
+15.6%
0.00%0.0%
Q2 2014$64,000
-13.5%
16,000
-59.8%
0.00%0.0%
Q1 2014$74,000
-6.3%
39,8000.0%0.00%0.0%
Q4 2013$79,000
+25.4%
39,800
+148.8%
0.00%
-50.0%
Q3 2013$63,000
+50.0%
16,000
-65.2%
0.00%
+100.0%
Q2 2013$42,00046,0000.00%
Other shareholders
ZIOPHARM ONCOLOGY INC shareholders Q1 2019
NameSharesValueWeighting ↓
Third Security, LLC 9,709,607$38,062,0002.76%
MILLER VALUE PARTNERS, LLC 5,037,946$19,749,0000.82%
MSD Partners, L.P. 3,410,500$13,369,0000.68%
Virtus ETF Advisers LLC 177,399$695,0000.60%
Michael & Susan Dell Foundation 66,749$262,0000.41%
G&S Capital LLC 30,300$119,0000.10%
Vident Investment Advisory, LLC 400,060$1,744,0000.07%
Wealthcare Advisory Partners LLC 80,000$314,0000.07%
Old West Investment Management, LLC 21,909$85,0000.05%
Prism Advisors, Inc. 18,812$85,0000.05%
View complete list of ZIOPHARM ONCOLOGY INC shareholders